Business Wire

Cirium: Radical Shifts in US Flight Schedules This Summer Reveal Why Airlines Need New Planning Tools to Stay Ahead of the Curve

27.10.2021 15:00:00 EEST | Business Wire | Press release

Share

The new DiioTM Schedule Snapshot offering released by Cirium, the aviation analytics firm, reveals how planning by the major US airlines changed over the summer, with 20% of flights being removed from their schedule for September.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005581/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The September flight schedules as published by American Airlines, Delta Air Lines, Southwest, and United Airlines initially in May compared with the revised plan published four months later. (Graphic: Business Wire)

At the start of May 2021, the plan for what carriers would fly in September was more or less in line with pre-pandemic levels in 2019. By the time they came to fly the September schedule, American Airlines, Delta Air Lines, Southwest and United Airlines had significantly cut back their flights.

Airlines are now making major changes to the way they schedule flights—publishing or removing them much closer to the date of departure as they struggle with the uncertainties brought on by the pandemic.

Prior to the pandemic schedules would remain fairly stable over a season, with few changes—positive or negative—as the plan was refined.

Only 3% of flights were removed from the September schedule in 2019 compared with the plan published in May that year.

The new Diio Schedule Snapshot web-based tool enables airlines and airports to track changes to the flights being scheduled at different points in time. It provides much more detail on schedule changes than has been done in the past.

“In today's environment where travel restrictions and vaccination programs are significantly impacting flight schedules, airlines have had to adapt and issue changes to their schedules frequently and much closer to the day of departure. The traditional methods used to analyze demand need to be more dynamic,” said Kevin O’Toole, Chief Strategy Officer at Cirium.

“Using Diio Schedules Snapshot, airlines and airports can understand schedule changes over time, optimize future schedules, build stronger models for planning and revenue management, and optimize yield through trend analysis.”

The analysis of the major US airlines evidences the radical shift in the summer flight schedule and the impact that the pandemic has had on the variance in airline planning year-over-year.

Understanding and comparing changes to the published flight schedule over time as it gets closer to actual departure, enables analysts to stay ahead of the curve, and provides new insights for planning and revenue management.

Reviewing historical data by publication date also provides insights on airline and airport strategies in an uncertain world.

Diio Schedule Snapshot is part of the unrivaled Cirium Diio suite of products for airline planning. The suite includes Diio Mi, SRS AnalyserTM, Cirium Scenario Planner, and Diio Traffic and Fares.

The new tool integrates with Cirium Diio Mi or SRS Analyser and is the first of many more new tools in the Cirium pipeline to help airlines optimize their schedules and find new revenue opportunities.

More information on Diio Schedule Snapshot can be found at https://cirium.com/products/views/diio-schedule-snapshot

-End-

For further information please visit https://www.cirium.com and follow Cirium updates via LinkedIn and Twitter.

About Cirium

Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media enquiries please contact:

Mike Arnot, Juliett Alpha via cirium@juliettalpha.com

or the Cirium media team at media@cirium.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f

Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye